Cure Ventures Fund II, L.P. · CIK 2094337
Cure Ventures Fund II, L.P.
Filings
1
Original notices
1
Amendments
0
Activity
Dec 18, 2025
through Dec 18, 2025
through Dec 18, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- —
- Reported exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(1), Investment Company Act Section 3(c)(7)
- Reported amount sold
- $0
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Crosslink Therapeutics Inc. · CIK 2067583
Form D filings (1)
-
0002094337-25-000001D · Dec 18, 2025 · Pooled Investment FundSold: $0